Full-text search

Results for “Ulta Salon, Cosmetics & Fragrance, Inc”

Search across the indexed text of every released document.

Names that match “Ulta Salon, Cosmetics & Fragrance, Inc”

HBRK Associates Inc · 73 ROYAL SAXON INC CO-OP · 59 REGENCY OF PALM BEACH INC · 52 PARK PLACE INC CO-OP · 27 New York Post Publishing INC · 18 USA Inc · 15

1,439 documents found

Inc. Therapeutics 2005 19.6 - 7.2 Pd. - 0.37 -14.6%

document Tioga Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2005 19.6 - 7.2 Pd. - 0.37 -14.6%

Inc. Therapeutics 2006 19.4 - 19.6 19.6 - 1.01 0.2%

document VaxInnate House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 19.4 - 19.6 19.6 - 1.01 0.2%

USA Inc. would have needed to raise individual income tax rates by

document time charges) House Oversight Committee — Epstein Estate Records (Nov 2025)

USA Inc. would have needed to raise individual income tax rates by

USA Inc. will not be immune to the sudden crises that have afflicted others

document IMAGES-006-HOUSE_OVERSIGHT_020841.txt,With these trends House Oversight Committee — Epstein Estate Records (Nov 2025)

USA Inc. will not be immune to the sudden crises that have afflicted others

Enterprise Strategic Planning Aetna Inc. USA

document Michael Flammini Head House Oversight Committee — Epstein Estate Records (Nov 2025)

Enterprise Strategic Planning Aetna Inc. USA

EMEA and Asia Pacific SAS Institute Inc. USA

document Mikael Hagström President House Oversight Committee — Epstein Estate Records (Nov 2025)

EMEA and Asia Pacific SAS Institute Inc. USA

Supply Chain and Nestle - Jenny Craig Inc. USA

document Stephanie Pullings Hart Vice-President House Oversight Committee — Epstein Estate Records (Nov 2025)

Supply Chain and Nestle - Jenny Craig Inc. USA

Inc. (fka GoToMyDoc) Convergence 2000 2.0 0.0 - 0.0 0.02 0.02 -92.8%

document AviaHealth House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. (fka GoToMyDoc) Convergence 2000 2.0 0.0 - 0.0 0.02 0.02 -92.8%

Inc. Therapeutics 1999 5.1 25.6 - 25.6 5.01 5.01 293.2%

document Cephalon House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 1999 5.1 25.6 - 25.6 5.01 5.01 293.2%

Inc. Therapeutics 1998 19.9 41 - 41 0.20 0.20 -30.3%

document Deltagen House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 1998 19.9 41 - 41 0.20 0.20 -30.3%

Inc. Convergence 1999 11.3 20.3 - 20.3 1.80 1.80 7.7%

document eHealth House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Convergence 1999 11.3 20.3 - 20.3 1.80 1.80 7.7%

Inc. Healthcare Devices 1999 17.8 50.3 - 50.3 2.83 2.83 14.2%

document NxStage Medical House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Healthcare Devices 1999 17.8 50.3 - 50.3 2.83 2.83 14.2%

Inc. Therapeutics 2000 15.0 1.6 - 1.6 0.11 0.11 -35.3%

document SGX House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2000 15.0 1.6 - 1.6 0.11 0.11 -35.3%

Inc. Convergence 1998 9.0 0.0 - 0.0 0.00 0.00 NM

document Skila House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Convergence 1998 9.0 0.0 - 0.0 0.00 0.00 NM

Inc. Convergence 1999 99 24.8 - 24.8 2.50 2.50 12.7%

document Spotfire House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Convergence 1999 99 24.8 - 24.8 2.50 2.50 12.7%